- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pneumococcal Vaccine market size is estimated to be worth US$ 7408.6 million in 2021 and is forecast to a readjusted size of USD 7972.1 million by 2028 with a CAGR of 1.1% during review period. Child accounting for % of the Pneumococcal Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PPSV 23 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur, and CDIBP, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pneumococcal Vaccine market is split by Type and by End User. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PPSV 23
PCV 7/13
PCV 10
Market segment by End User can be divided into
Child
Adult
The key market players for global Pneumococcal Vaccine market are listed below:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine from 2019 to 2022.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, end user, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pneumococcal Vaccine market forecast, by regions, type and end user, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine.
Chapter 13, 14, and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market Analysis by End User
1.3.1 Overview: Global Pneumococcal Vaccine Revenue by End User: 2017 Versus 2021 Versus 2028
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccine Market Size & Forecast
1.4.1 Global Pneumococcal Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pneumococcal Vaccine Sales in Volume (2017-2028)
1.4.3 Global Pneumococcal Vaccine Price (2017-2028)
1.5 Global Pneumococcal Vaccine Production Capacity Analysis
1.5.1 Global Pneumococcal Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Pneumococcal Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pneumococcal Vaccine Market Drivers
1.6.2 Pneumococcal Vaccine Market Restraints
1.6.3 Pneumococcal Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Pneumococcal Vaccine Product and Services
2.1.4 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pneumococcal Vaccine Product and Services
2.2.4 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Pneumococcal Vaccine Product and Services
2.3.4 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofipasteur
2.4.1 Sanofipasteur Details
2.4.2 Sanofipasteur Major Business
2.4.3 Sanofipasteur Pneumococcal Vaccine Product and Services
2.4.4 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business
2.5.3 CDIBP Pneumococcal Vaccine Product and Services
2.5.4 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pneumococcal Vaccine Breakdown Data by Manufacturer
3.1 Global Pneumococcal Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pneumococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pneumococcal Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2021
3.5 Global Pneumococcal Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pneumococcal Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pneumococcal Vaccine Market Size by Region
4.1.1 Global Pneumococcal Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Pneumococcal Vaccine Revenue by Region (2017-2028)
4.2 North America Pneumococcal Vaccine Revenue (2017-2028)
4.3 Europe Pneumococcal Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Pneumococcal Vaccine Revenue (2017-2028)
4.5 South America Pneumococcal Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Pneumococcal Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pneumococcal Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Pneumococcal Vaccine Revenue by Type (2017-2028)
5.3 Global Pneumococcal Vaccine Price by Type (2017-2028)
6 Market Segment by End User
6.1 Global Pneumococcal Vaccine Sales in Volume by End User (2017-2028)
6.2 Global Pneumococcal Vaccine Revenue by End User (2017-2028)
6.3 Global Pneumococcal Vaccine Price by End User (2017-2028)
7 North America by Country, by Type, and by End User
7.1 North America Pneumococcal Vaccine Sales by Type (2017-2028)
7.2 North America Pneumococcal Vaccine Sales by End User (2017-2028)
7.3 North America Pneumococcal Vaccine Market Size by Country
7.3.1 North America Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Pneumococcal Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by End User
8.1 Europe Pneumococcal Vaccine Sales by Type (2017-2028)
8.2 Europe Pneumococcal Vaccine Sales by End User (2017-2028)
8.3 Europe Pneumococcal Vaccine Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Pneumococcal Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by End User
9.1 Asia-Pacific Pneumococcal Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Pneumococcal Vaccine Sales by End User (2017-2028)
9.3 Asia-Pacific Pneumococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pneumococcal Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by End User
10.1 South America Pneumococcal Vaccine Sales by Type (2017-2028)
10.2 South America Pneumococcal Vaccine Sales by End User (2017-2028)
10.3 South America Pneumococcal Vaccine Market Size by Country
10.3.1 South America Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Pneumococcal Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by End User
11.1 Middle East & Africa Pneumococcal Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Pneumococcal Vaccine Sales by End User (2017-2028)
11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pneumococcal Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pneumococcal Vaccine
12.3 Pneumococcal Vaccine Production Process
12.4 Pneumococcal Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pneumococcal Vaccine Typical Distributors
13.3 Pneumococcal Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Pneumococcal Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pneumococcal Vaccine Revenue by End User, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Pneumococcal Vaccine Product and Services
Table 6. Pfizer Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Pneumococcal Vaccine Product and Services
Table 10. GSK Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. MSD Basic Information, Manufacturing Base and Competitors
Table 12. MSD Major Business
Table 13. MSD Pneumococcal Vaccine Product and Services
Table 14. MSD Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 16. Sanofipasteur Major Business
Table 17. Sanofipasteur Pneumococcal Vaccine Product and Services
Table 18. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CDIBP Basic Information, Manufacturing Base and Competitors
Table 20. CDIBP Major Business
Table 21. CDIBP Pneumococcal Vaccine Product and Services
Table 22. CDIBP Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Pneumococcal Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 24. Global Pneumococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Pneumococcal Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 27. Head Office and Pneumococcal Vaccine Production Site of Key Manufacturer
Table 28. Pneumococcal Vaccine New Entrant and Capacity Expansion Plans
Table 29. Pneumococcal Vaccine Mergers & Acquisitions in the Past Five Years
Table 30. Global Pneumococcal Vaccine Sales by Region (2017-2022) & (K Doses)
Table 31. Global Pneumococcal Vaccine Sales by Region (2023-2028) & (K Doses)
Table 32. Global Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 35. Global Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 36. Global Pneumococcal Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Pneumococcal Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Pneumococcal Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 39. Global Pneumococcal Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 40. Global Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 41. Global Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 42. Global Pneumococcal Vaccine Revenue by End User (2017-2022) & (USD Million)
Table 43. Global Pneumococcal Vaccine Revenue by End User (2023-2028) & (USD Million)
Table 44. Global Pneumococcal Vaccine Price by End User (2017-2022) & (USD/Dose)
Table 45. Global Pneumococcal Vaccine Price by End User (2023-2028) & (USD/Dose)
Table 46. North America Pneumococcal Vaccine Sales by Country (2017-2022) & (K Doses)
Table 47. North America Pneumococcal Vaccine Sales by Country (2023-2028) & (K Doses)
Table 48. North America Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. North America Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 52. North America Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 53. North America Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 54. Europe Pneumococcal Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. Europe Pneumococcal Vaccine Sales by Country (2023-2028) & (K Doses)
Table 56. Europe Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 60. Europe Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 61. Europe Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 62. Asia-Pacific Pneumococcal Vaccine Sales by Region (2017-2022) & (K Doses)
Table 63. Asia-Pacific Pneumococcal Vaccine Sales by Region (2023-2028) & (K Doses)
Table 64. Asia-Pacific Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. Asia-Pacific Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 68. Asia-Pacific Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 69. Asia-Pacific Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 70. South America Pneumococcal Vaccine Sales by Country (2017-2022) & (K Doses)
Table 71. South America Pneumococcal Vaccine Sales by Country (2023-2028) & (K Doses)
Table 72. South America Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 75. South America Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 76. South America Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 77. South America Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 78. Middle East & Africa Pneumococcal Vaccine Sales by Region (2017-2022) & (K Doses)
Table 79. Middle East & Africa Pneumococcal Vaccine Sales by Region (2023-2028) & (K Doses)
Table 80. Middle East & Africa Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Pneumococcal Vaccine Sales by Type (2017-2022) & (K Doses)
Table 83. Middle East & Africa Pneumococcal Vaccine Sales by Type (2023-2028) & (K Doses)
Table 84. Middle East & Africa Pneumococcal Vaccine Sales by End User (2017-2022) & (K Doses)
Table 85. Middle East & Africa Pneumococcal Vaccine Sales by End User (2023-2028) & (K Doses)
Table 86. Pneumococcal Vaccine Raw Material
Table 87. Key Manufacturers of Pneumococcal Vaccine Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Pneumococcal Vaccine Typical Distributors
Table 91. Pneumococcal Vaccine Typical Customers
List of Figures
Figure 1. Pneumococcal Vaccine Picture
Figure 2. Global Pneumococcal Vaccine Revenue Market Share by Type in 2021
Figure 3. PPSV 23
Figure 4. PCV 7/13
Figure 5. PCV 10
Figure 6. Global Pneumococcal Vaccine Revenue Market Share by End User in 2021
Figure 7. Child
Figure 8. Adult
Figure 9. Global Pneumococcal Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 10. Global Pneumococcal Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pneumococcal Vaccine Sales (2017-2028) & (K Doses)
Figure 12. Global Pneumococcal Vaccine Price (2017-2028) & (USD/Dose)
Figure 13. Global Pneumococcal Vaccine Production Capacity (2017-2028) & (K Doses)
Figure 14. Global Pneumococcal Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pneumococcal Vaccine Market Drivers
Figure 16. Pneumococcal Vaccine Market Restraints
Figure 17. Pneumococcal Vaccine Market Trends
Figure 18. Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Pneumococcal Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Pneumococcal Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 33. Global Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 34. Global Pneumococcal Vaccine Revenue Market Share by End User (2017-2028)
Figure 35. Global Pneumococcal Vaccine Price by End User (2017-2028) & (USD/Dose)
Figure 36. North America Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 38. North America Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 45. Europe Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 54. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 64. South America Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User (2017-2028)
Figure 70. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 78. Pneumococcal Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
